
Novo Nordisk overtook SAP and once again became the most valuable company in Europe with a valuation of $365 billion
Shares in Danish drugmaker Novo Nordisk rose 2.3% on Friday after Novo said it plans to move its experimental weight-management drug Amicretin into late-stage